Commentary: Bettering BCG: a tough task for a TB vaccine?

• Brahm S. Srivastava,
• Vipul K. Singh,
• Vivek K. Kashyap,
• Ranjana Srivastava,
• Arshad Khan,
• Chinnaswamy Jagannath

Affiliations

Brahm S. Srivastava

Nextec Lifesciences, Lucknow, India

Vipul K. Singh

Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, United States

Vivek K. Kashyap

Department of Immunology and Microbiology, University of Texas Rio Grande Valley, McAllen, TX, United States

Ranjana Srivastava

Nextec Lifesciences, Lucknow, India

Arshad Khan

Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, United States

Chinnaswamy Jagannath

Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, United States